RWE analytics platform enabling causal inference from real-world data for regulatory submissions. Partners with FDA,EMA,and major pharma. CARE Initiative for RCT emulation in oncology.
Vendor description
Regulatory-grade causal inference RWE platform
Regulatory RWE submissions,Causal inference analytics,HTA evidence generation,RCT emulation
- FDA and EMA partnerships
- Causal inference methodology
- Regulatory acceptance track record
- CARE Initiative for RCT emulation
- Analytics platform only (no data collection)
- Requires external data partnerships
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | SaaS |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Small,Medium,Large |
| Therapeutic areas | Oncology, Rare diseases, Cardiovascular, Immunology, Neurology |
Related vendors
Editorial ranking
See how Aetion compares - best Biometrics / data science vendors for clinical trials.